Form 4: Ingevity Corp Director Karen G. Narwold Reports Acquisition of Deferred Stock Units
SEC Form 4 Filing
Director Karen G. Narwold reports the acquisition of 4,057 deferred stock units (DSUs) in Ingevity Corp, vesting on May 1, 2026, and also grants a limited power of attorney for SEC reporting purposes.
Summary
- Karen G. Narwold, a director of Ingevity Corp, filed a Form 4 on May 05, 2025, reporting a transaction that occurred on May 01, 2025.
- The transaction involved the acquisition of 4,057 deferred stock units (DSUs) at a price of $0.
- Following the transaction, Narwold beneficially owns 16,996 shares of Ingevity Corp common stock.
- The DSUs will vest on May 1, 2026, and will settle into an equal number of shares upon termination of board service.
- Narwold also granted a limited power of attorney to Ryan C. Fisher, Mavis G. Huger, and any duly appointed Corporate Secretary of Ingevity Corporation for SEC reporting purposes.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The acquisition of DSUs by a director signals confidence in the company's future, while the power of attorney is a procedural matter.
Positives
- The acquisition of deferred stock units aligns the director's interests with the long-term performance of the company.
- The grant of a limited power of attorney simplifies SEC reporting processes.
Future Outlook
The deferred stock units will vest on May 1, 2026, and convert into common stock upon termination of board service, indicating a long-term commitment.
Industry Context
Form 4 filings are standard practice for reporting insider transactions and are closely monitored by investors for insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Director compensation packages often include deferred stock units to align director interests with shareholder value, a common practice among publicly traded companies.
- The vesting schedule of the DSUs is typical for director compensation plans.
Stakeholder Impact
- The acquisition of deferred stock units by a director can positively influence shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 2025-04-29 | Date of execution for the Limited Power of Attorney. |
| 2025-05-01 | Date of transaction: Acquisition of deferred stock units. |
| 2025-05-05 | Date of Form 4 filing. |
| 2026-05-01 | Vesting date of the deferred stock units. |
Keywords
Form 4, deferred stock units, DSUs, director, beneficial ownership, power of attorney, SEC reporting, Ingevity Corp, NGVT
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.